Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
184M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
60.7M
-
Shares change
-
+3.4M
-
Total reported value, excl. options
-
$841M
-
Value change
-
+$47.5M
-
Put/Call ratio
-
0.04
-
Number of buys
-
59
-
Number of sells
-
-35
-
Price
-
$13.85
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q2 2017
125 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock as of Q2 2017.
HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.7M shares
of 184M outstanding shares and own 33.09% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (8.38M shares), FMR LLC (8.05M shares), JANUS HENDERSON GROUP PLC (5.64M shares), Broadfin Capital, LLC (4.42M shares), Partner Fund Management, L.P. (3.34M shares), BlackRock Inc. (2.8M shares), BAKER BROS. ADVISORS LP (2.78M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (2.31M shares), VANGUARD GROUP INC (2.1M shares), and CARLSON CAPITAL L P (2.09M shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.